🔎 Trials Near Me

홈 › 루푸스 › 캘리포니아

캘리포니아의 루푸스 임상 시험

루푸스 관련 연구 27개가 캘리포니아 내 여러 지역에서 참여자를 모집하고 있습니다.

캘리포니아의 도시

공식 연구 텍스트(영어)

A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus

  • Research Site, Fontana
  • Research Site, La Jolla
  • Research Site, La Palma
  • 외 3개
피험자 모집 중3상
18세 ~ 70세 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07430306

A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus

  • David S Hallegua MD A Professional Corporation, Beverly Hills
  • Providence Medical Foundation, Fullerton
  • Southland Arthritis and Osteoporosis Medical Center Inc dba Southland Arthritis, Hemet
  • 외 5개
피험자 모집 중3상
18세 ~ 75세 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07438496

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • University of California Davis Comprehensive Cancer Center, Sacramento
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT03816345

Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants

  • Research Site, Fullerton
피험자 모집 중1상
18세 ~ 65세 · 모든 성별 · 2026. 9. 18. 업데이트됨 · NCT07201558

A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)

  • Wallace & Lee Center, Beverly Hills
  • Arthritis & Osteoporosis Medical Center, Inc - La Palma, La Palma
  • University of California San Diego, San Diego
  • 외 3개
피험자 모집 중2상
18세 ~ 74세 · 모든 성별 · 2026. 9. 17. 업데이트됨 · NCT07409181

A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.

  • Research Site, La Jolla
  • Research Site, Sacramento
피험자 모집 중1상
18세 ~ 70세 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT06916806

A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)

  • Inland Rheumatology Clinical Trials, Inc., Upland
피험자 모집 중3상
18세 ~ 75세 · 모든 성별 · 2026. 9. 14. 업데이트됨 · NCT07355218

Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis

  • University of California San Francisco - Zuckerberg San Francisco General, San Francisco
피험자 모집 중1상
18세 ~ 60세 · 모든 성별 · 2026. 9. 14. 업데이트됨 · NCT06975787

A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis

  • Wallace Rheumatic Studies Center, Beverly Hills
  • Kaiser Permanente Fontana, Fontana
  • Providence Medical Foundation, Fullerton
  • 외 2개
피험자 모집 중2상
12세 ~ 70세 · 모든 성별 · 2026. 9. 14. 업데이트됨 · NCT07570862

A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease

  • Dermatology Research Associates - 300204025, Los Angeles
  • Cohen Medical Centers, Thousand Oaks
피험자 모집 중3상
18세 ~ 75세 · 모든 성별 · 2026. 9. 11. 업데이트됨 · NCT07332481

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

  • Loma Linda University Medical Center, Loma Linda
피험자 모집 중1상
18세 ~ 74세 · 모든 성별 · 2026. 9. 10. 업데이트됨 · NCT07085104

An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants

  • Research Site, Los Angeles
피험자 모집 중3상
5세 ~ 17세 · 모든 성별 · 2026. 9. 10. 업데이트됨 · NCT05835310

A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE

  • Research Site, San Francisco
  • Research Site, Stanford
피험자 모집 중1/2상
18세 ~ 70세 · 모든 성별 · 2026. 9. 10. 업데이트됨 · NCT06897930

A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

  • Sl0044 50737, Beverly Hills
  • Sl0044 50775, Beverly Hills
  • Sl0044 50257, La Jolla
  • 외 6개
피험자 모집 중3상
16세 이상 · 모든 성별 · 2026. 9. 4. 업데이트됨 · NCT06617325

A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants

  • Local Institution - 0054, La Jolla
  • Local Institution - 0001, La Palma
  • Local Institution - 0071, Los Angeles
  • 외 1개
피험자 모집 중관찰 연구
16세 이상 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT07175285

FT839 in Autoimmune Diseases

  • Providence Medical Foundation, Fullerton
피험자 모집 중1/2상
18세 ~ 70세 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT07800871

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

  • UC San Diego Health, La Jolla
  • Stanford University Medical Center, Redwood City
피험자 모집 중1상
18세 ~ 70세 · 모든 성별 · 2026. 8. 28. 업데이트됨 · NCT06925542

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

  • University of California Irvine, Orange
  • UC Davis Health, Sacramento
피험자 모집 중1/2상
18세 ~ 65세 · 모든 성별 · 2026. 8. 26. 업데이트됨 · NCT06121297

Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease

  • University of California, Los Angeles, Los Angeles
  • University of California: San Diego, San Diego
피험자 모집 중3상
55세 이상 · 모든 성별 · 2026. 8. 20. 업데이트됨 · NCT05799378

Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V

  • Ronald Reagan UCLA Medical Center, Los Angeles
피험자 모집 중2상
18세 ~ 100세 · 모든 성별 · 2026. 7. 30. 업데이트됨 · NCT05268289

Phase 1a/b Tolerability of NTR-1011 in Healthy Adults and Adult Patients With SLE and RA

  • Carewell Arthritis Center, Apple Valley
  • Attune Health Research Inc, Beverly Hills
  • Covina Arthritis Clinic, Covina
  • 외 4개
피험자 모집 중1상
18세 ~ 75세 · 모든 성별 · 2026. 7. 20. 업데이트됨 · NCT07237659

Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).

  • Providence Medical Center, Burbank
  • Advanced Medical Research, La Palma
피험자 모집 중3상
12세 ~ 100세 · 모든 성별 · 2026. 7. 8. 업데이트됨 · NCT06133972

A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE/CLE Participants

  • US06-0, La Palma
피험자 모집 중1/2상건강한 지원자 환영
18세 ~ 70세 · 모든 성별 · 2026. 6. 2. 업데이트됨 · NCT06625671

A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

  • Wallace Rheumatic Center, Beverly Hills
  • Providence Medical Foundation, Fullerton
  • University of California Irvine, Irvine
  • 외 2개
피험자 모집 중1상
12세 ~ 70세 · 모든 성별 · 2026. 5. 22. 업데이트됨 · NCT06308978

Lupus Landmark Study: A Prospective Registry and Biorepository

  • Wallace Rheumatic Studies Center, Beverly Hills
  • UCLA, Los Angeles
피험자 모집 중관찰 연구
18세 ~ 110세 · 모든 성별 · 2026. 4. 15. 업데이트됨 · NCT05934149

ClinicalTrials.gov 출처, 2026. 9. 30. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.